17-35981384-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_004590.4(CCL16):c.37C>T(p.Leu13Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000335 in 1,612,986 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_004590.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCL16 | NM_004590.4 | c.37C>T | p.Leu13Phe | missense_variant | 1/3 | ENST00000611905.2 | NP_004581.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCL16 | ENST00000611905.2 | c.37C>T | p.Leu13Phe | missense_variant | 1/3 | 1 | NM_004590.4 | ENSP00000478024.1 | ||
CCL16 | ENST00000610493.1 | n.37C>T | non_coding_transcript_exon_variant | 1/5 | 5 | ENSP00000478934.1 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152184Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000321 AC: 8AN: 249316Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134730
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1460802Hom.: 0 Cov.: 30 AF XY: 0.0000165 AC XY: 12AN XY: 726588
GnomAD4 genome AF: 0.000118 AC: 18AN: 152184Hom.: 0 Cov.: 32 AF XY: 0.0000942 AC XY: 7AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2024 | The c.37C>T (p.L13F) alteration is located in exon 1 (coding exon 1) of the CCL16 gene. This alteration results from a C to T substitution at nucleotide position 37, causing the leucine (L) at amino acid position 13 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at